The role of CD28 costimulation in immune-mediated responses against mouse mammary tumor viruses

Journal of Immunology

Volumn 156, Issue 6, 1996, Pages 2112-2118

  Palmer, Larry D ^a   Saha, Bhaskar ^b   Hodes, Richard J ^a,d   Abe, Ryo ^b,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

^d NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; GENE DELETION; INFECTION SENSITIVITY; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; VIRUS IMMUNITY;

ANIMALS; ANTIGENS, CD28; B-LYMPHOCYTES; CYTOKINES; IMMUNITY, CELLULAR; IMMUNOPHENOTYPING; INJECTIONS, SUBCUTANEOUS; LYMPHOCYTE DEPLETION; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RETROVIRIDAE INFECTIONS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TUMOR VIRUS INFECTIONS;

EID: 0029929376     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Jenkins, M. K. 1994. The ups and downs of T cell costimulation. Immunity 1:443.
2. Blankson, J N., and S S. Morse. 1994 The CD28/B7 pathway costimulates the response of primary murine T cells to superantigens as well as conventional antigens. Cell. Immunol. 157:306.
3. Shahinian, A., K Pfeffer, K. P. Lee, T. M. Kundig, K. Kishihara, A Wakeham, K. Kawai, P S Obashi, C B. Thompson, and T. W. Mak. 1993. Differential T cell costimulation requirements in CD28-deficient mice. Science 261:609
4. Marrack, P., G. M Winslow, Y. Choi, M. Scherer, A. Pullen, J. White, and J. W. Kappler. 1993. The bacterial and mouse mammary tumor virus superantigens: two different families of proteins with the same functions. Immunol. Rev. 131.79.
5. Pucillo, C., R. Cepeda, and R. J Hodes. 1993. Expression of a MHC class II transgene determines both superantigenicity and susceptibility to mouse mammary tumor virus infection. J. Exp. Med. 178.1441.
6. Karapetian, O , A. N. Shakhov, J. P. Kraehenbuhl, and H. Acha-Orbea. 1994. Retroviral infection of neonatal Peyer's patch lymphocytes: the mouse mammary tumor virus model. J. Exp. Med. 180:1511.
7. Golovkina, T. V., J. P. Dudley, A. B Jaffe, and S R. Ross. 1995. Mouse mammary tumor viruses with functional superantigen genes are selected during in vivo infection. Proc Natl Acad. Sci. USA 92:4828.
8. Pucillo, C. E. M., L. D. Palmer, and R. J. Hodes. 1995. Superantigenic characteristics of mouse mammary tumor viruses play a critical role in susceptibility to infection in mice Immunol. Rev. 14:58.
9. + T cells are required to stimulate B cells after infection with mouse mammary tumor virus. J. Exp. Med. 177:359.
10. Hodes, R J , M. B. Novick, L. D. Palmer, and J. A. Knepper. 1993. Association of a V β 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus. J. Immunol 150:1422.
11. Held, W., G A. Waanders, A. N. Sakhov, L. Scarpellino, H. Acha-Orbea, and H. R. MacDonald 1993. Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell 74:529.
12. Matsuzawa, A , H. Nakano, T Yoshimoto, and K. Sayama. 1995. Biology of mouse mammary tumor viruses (MMTV). Cancer Lett. 90:3.
13. + T cells in an Mls-1b BALB/c colony infected with an exogenous mouse mammary tumor virus. J. Immunol. 151:759
14. Dannecker, G., U. Mahlknecht, H. Schultz, N K. Hoffmann, and D. Niethammer 1994. Activation of human T cells by the superantigen staphylococcus enterotoxin B: analysis on a cellular level. Immunobiology 190:116
15. Abraham, R. T., L. M. Karnitz, J. P. Secrist, and P. J Leibson 1992. Signal transduction through the T-cell antigen receptor. Trends. Biochem. Sci. 17 434
16. Golovkina, T. V., J. A Prescott, and S R. Ross. 1993. Mouse mammary tumor virus-induced tumorigenesis in SAg transgenic mice: a laboratory model of natural selection. J. Virol. 67:7690.
17. Dennig, D., and R. J. O'Reilly 1993. Dissection of the function of HLA class II and coslimulation in B cell-mediated and toxic shock syndrome toxin-1-induced T cell proliferation J. Immunol. 150.5231
18. Mottershead, D. G., P. N. Hsu, R. G Urban, J L. Strominger, and B. T. Huber. 1995 Direct binding of the Mtv7 superantigen (Mls-1) to soluble MHC class II molecules. Immunity 2 149.
19. Obnishi, H., T. Tanaka, J. Takahara, and M. Kotb. 1993. CB28 delivers costimulatory signals for superantigen-induced activation of antigen-presenting cell-depleted human T lymphocytes. J. Immunol. 150:3207.
20. Muraille, E , T. De Smedt, K. Thielmans, J. Urbain, M. Moser, and O. Leo. 1995. Activation of murine T cells by bacterial superantigens requires B7-mediated costimulation Cell. Immunol. 162.315.
21. Ohnishi, H., J. A. Ledbetter, S. B. Kanner, P. S. Linsley, T Tanaka, A M. Geller, and M. Kotb. 1995. CD28 cross-linking augments TCR-mediated signals and costimulates superantigen responses. J. Immunol. 154:3180.
22. Heeg, K., and H. Wagner. 1995. Induction of responsiveness in superantigen-induced anergic T cells: role of ligand density and costimulatory signals. J. Immunol. 155:83
23. Jones, L. A., D J. Izon, J. D. Nieland. P. S. Linsley, and A. M Kruisbeek 1993. CD28-B7 interactions are not required for intrathymic clonal deletion Int. Immunol. 5:503.
24. + thymocytes. J Immunol. 152:3254.
25. Finkelman, F D., J. Holmes, I M. Katona, J. F. Urbain, M. P. Beckmann, L S Park, K. A. Schooley, R. L Coffman, T. R. Mosmann, and W. E. Paul 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 8:303
26. Rocken, M., J. Urban, and E. M. Shevach 1994 Antigen-specific activation, tolerization and reactivation of the interleukin 4 pathway in vivo. J Exp. Med. 179:1885.
27. Sommer, F., M. Rollinghoff, and M. Lohoff. 1993. Signalling via CD28 costimulates lymphokine production, but does not reverse unresponsiveness to interleukin-2 in anti-CD3 triggered Th1 cells. Eur. J. Immunol 23:2498.
28. Fraser, J. D., M. E. Newton, and A. Weiss. 1992. CD28 and T cell antigen receptor signal transduction coordinately regulate interleukin 2 gene expression in response to superantigen stimulation J. Exp. Med. 175.1131.
29. Sayegh, M H., E. Akalin, W. W. Hancock, M. E. Russell, C. B. Carpenter, P. S. Linsley, and L A Turka. 1995. CD28-B7 blockade after alloantigenic challenge inhibits Th1 cytokines but spares Th2. J. Exp. Med 181.1869.
30. Kubin, M., M Kamoun, and G. Trichieri 1994. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J. Exp. Med. 180:211.
31. Kuchroo, V K., M. P. Das, J. A Brown, A. M. Ranger, S. S. Zanvil, R. A. Sobel, H. L. Weiner, N Nabavi, and L. H Glimcher 1995 B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707
32. + T helper lymphocytes. Eur. J. Immunol. 23:2565.
33. Seder, R. A., R. N Germain, P. S. Linsley, and W. E Paul. 1994. CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon γ production. J. Exp Med. 179:299
34. Green, J M , P J Noci, A. I. Sperling, T. L. Walunas, G. S. Gray, J. A. Bluestone, and C B. Thompson. 1994. Absence of B7-dependent responses in CD28-deficient mice. Immunity 1:501.
35. Damle, N K., K. Klussman, G. Leytze, and P. S. Linsley. 1993. Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7. J. Immunol. 150.726
36. - cytotoxic lymphocytes. Eur. J. Immunol. 23 418.
37. Held, W., G. A. Waanders, H. Acha-Orbea, and H. R MacDonald. 1994. Reverse transcriptase-dependent and -independent phases of infection by mouse mammary tumor virus, implications for superantigen function J. Exp. Med. 180:2347.
38. Chervonsky, A. V., J. Xu, A. K Barlow, M. Khery, R. A. Flavell, and C A. Janeway, Jr. 1995. Direct physical interaction involving CD40 ligand on T cells and CD40 on B cells is required to propagate MMTV. Immunity 3:139.
39. Beutner, U., E. Kraus, D. Kitamura, K Rajewsky, and B T. Huber, 1994 B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens. J. Exp. Med. 179:1457.